Publication:
Complementary and alternative medicine use in lung cancer patients in eight European Countries

dc.contributor.coauthorMolassiotis, A.
dc.contributor.coauthorPanteli, V.
dc.contributor.coauthorPatiraki, E.
dc.contributor.coauthorOzden, G.
dc.contributor.coauthorMadsen, E.
dc.contributor.coauthorBrowall, M.
dc.contributor.coauthorFernandez-Ortega, P.
dc.contributor.coauthorPud, D.
dc.contributor.coauthorMargulies, A.
dc.contributor.departmentN/A
dc.contributor.kuauthorPlatin, Nurgün
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Nursing
dc.contributor.yokid191329
dc.date.accessioned2024-11-09T22:56:49Z
dc.date.issued2006
dc.description.abstractThis paper presents findings from a cross-sectional survey about the use of complementary and alternative medicine (CAM) in patients with lung cancer, forming part of a larger study. Data from 111 lung cancer patients in 8 countries in Europe were collected through a descriptive 27-item questionnaire. The data suggest that 23.6% of the lung cancer patients used CAM after the diagnosis with cancer. The most popular CAM modalities were herbal medicine (48.1%), medicinal teas (11.5%), homeopathy (11.5%), use of animal extracts (11.5%) and spiritual therapies (11.5%). Herbal use increased by three times after the diagnosis of cancer. Patients seemed quite satisfied with the CAM used. They were also spending on average about 142 Euros monthly on CAM therapies or remedies. The most common motivation to use CAM was to increase the body's ability to fight the cancer. Main sources of information about CAM were friends and family. As CAM is increasingly used by patients with lung cancer, it is important to be able to assist patients make an appropriate decision by discussing the issue of CAM openly, providing reassurance and communicating safe and appropriate information to patients.
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume12
dc.identifier.doi10.1016/j.ctcp.2005.09.007
dc.identifier.issn1744-3881
dc.identifier.linkhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-30344451710&doi=10.1016%2fj.ctcp.2005.09.007&partnerID=40&md5=b8f36ed350ed76a91e2b0b54a7ab7fef
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-30344451710
dc.identifier.uriN/A
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7448
dc.keywordsAlternative medicine
dc.keywordsComplementary medicine
dc.keywordsComplementary therapies
dc.keywordsLung cancer adult
dc.keywordsaged
dc.keywordsalternative medicine
dc.keywordsarticle
dc.keywordsCross-sectional study
dc.keywordsDecision making
dc.keywordsEpidemiology
dc.keywordsEurope
dc.keywordsfamily
dc.keywordsFemale
dc.keywordsFriend
dc.keywordsHuman
dc.keywordsIsrael
dc.keywordsLung tumor
dc.keywordsMale
dc.keywordsMethodology
dc.keywordsMiddle aged
dc.keywordsMotivation
dc.keywordsPatient attitude
dc.keywordsPatient education
dc.keywordsPsychological aspect
dc.keywordsQuestionnaire
dc.keywordsSocioeconomics
dc.keywordsStatistics
dc.keywordsTreatment outcome
dc.keywordsTurkey (republic)
dc.keywordsUtilization review
dc.keywordsAdult
dc.keywordsAged
dc.keywordsAged, 80 and over
dc.languageEnglish
dc.publisherElsevier
dc.sourceComplementary Therapies in Clinical Practice
dc.subjectAdaptation
dc.subjectPsychological adaptation
dc.subjectAdolescent
dc.titleComplementary and alternative medicine use in lung cancer patients in eight European Countries
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-6990-4329
local.contributor.kuauthorPlatin, Nurgün

Files